Nalaganje...
Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers
Human epidermal growth factor receptor 2 (HER2, ERBB2) mutations occur in 3% of lung adenocarcinomas. While case reports and series have shown activity of HER2 targeted agents in these patients, little is known about outcomes of chemotherapies. Patients with stage IV HER2-mutant lung cancers at Memo...
Shranjeno v:
| izdano v: | Lung Cancer |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5305295/ https://ncbi.nlm.nih.gov/pubmed/27565914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2016.05.030 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|